Advertisement
News
Advertisement

Guided Therapeutics widens distribution after FDA disappointment

Mon, 10/14/2013 - 9:29am
Mass Device

Guided Therapeutics signs distribution deals to gain access to 86 million new potential patients, hoping to land a win after the FDA refused to accept the company's premarket approval application.

Guided Therapeutics widens distribution after FDA disappointment

Georgie-based Guided Therapeutics (OTC:GTHP) hasn't won many points after announcing increased distribution for its LuViva advanced cervical scanning system.

The device maker last week signed agreements with distributors that open up markets in France, Qatar, Malaysia, Indonesia and Bangladesh, extending the company's reach to around 86 million women aged 25-64, according to a company statement.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading